# Dalfampridine

NDC: 51407-246
Generic name: Dalfampridine
Labeler / Manufacturer: Golden State Medical Supply, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20180711
Marketing ended: 20260531
FDA application: ANDA206863

## Active ingredients

- DALFAMPRIDINE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51407-246"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51407-246
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9b301b27-a182-63d0-e053-2a95a90a10d7